Topics
Gliomas | Treatment | Targeted therapy | Dordaviprone (ONC201)
Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Dordaviprone (ONC201)
Faison SL, Batonga J, Arumugham T, Bartkus A, Morrison ME, Mullin
MJ, Tippin T, Naderer O.
A Phase 1
Study to Assess the Effect of Hepatic Impairment on the
Pharmacokinetics, Safety, and Tolerability of Dordaviprone.
J
Clin Pharmacol. 2025 Nov 15. doi:
10.1002/jcph.70129. PMID:
41239907. Interventional
study˰
ˍ